Clinical Trial Update: GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial at Massachusetts General Hospital is studying genetic links related to exposure to oral semaglutide, with participant recruitment ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rybelsus (semaglutide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Genetic Predisposition, Metabolic Diseases | Phase 4 | Status: RECRUITING